14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
PG vs MRK: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Merck & Co., Inc. (MRK) is the stronger overall head-to-head candidate over Procter & Gamble Company (PG) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, R&D & Supply-Chain Moat). PG carries a Unified Composite Score of 33.6/100 (SELL) at $169.37 (24.0x Forward P/E, 24.9% operating margin), whereas MRK carries 55.3/100 (HOLD) at $133.72 (14.9x Forward P/E, 35.2% operating margin).
Technical & Structure Timing Caution: PG trades in a Markup technical trend (SURGE options phase, RSI 61.0); meanwhile MRK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Household & Personal Products value chain with $389.0B market capitalization and 24.9% operating margin.
OpEx & R&D Reinvestment25.7% of Rev ($22.6B)
90D Engineering Disclosures0 Published
MRK Moat ProfileHigh-Margin Pricing Power Moat
Drug Manufacturers - General Operator
Competes within the Drug Manufacturers - General value chain with $327.4B market capitalization and 35.2% operating margin.
OpEx & R&D Reinvestment40.0% of Rev ($27.0B)
90D Engineering Disclosures0 Published
Investor FAQ PG vs MRK Key Questions & Quantitative Answers
As of Nov 20, 2026, Merck & Co., Inc. (MRK) is the stronger overall head-to-head candidate over Procter & Gamble Company (PG) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, R&D & Supply-Chain Moat). PG carries a Unified Composite Score of 33.6/100 (SELL) at $169.37 (24.0x Forward P/E, 24.9% operating margin), whereas MRK carries 55.3/100 (HOLD) at $133.72 (14.9x Forward P/E, 35.2% operating margin). Technical & Structure Timing Caution: PG trades in a Markup technical trend (SURGE options phase, RSI 61.0); meanwhile MRK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
PG leads the Growth & Scale pillar: PG posts +4.0% YoY revenue growth and +0.8% YoY earnings growth on $87.9B TTM revenue (50.6% gross margin, 24.9% operating margin), compared with MRK at +4.7% YoY revenue growth and -12.0% YoY earnings growth on $67.4B TTM revenue (75.2% gross margin, 35.2% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), PG cumulative revenue shifted +28.6% while MRK shifted +66.2%. In operating R&D and SG&A reinvestment, PG deploys 25.7% of Rev ($22.6B) (0 90-day corporate R&D disclosures) versus 40.0% of Rev ($27.0B) (0 disclosures) for MRK.
MRK screens cheaper on headline valuation multiples. PG trades at 24.0x Forward P/E, 25.3x Trailing P/E, 4.38x PEG, and 4.7x EV/Revenue (17.4% FCF margin), whereas MRK trades at 14.9x Forward P/E, 134.2x Trailing P/E, 3.33x PEG, and 5.5x EV/Revenue (21.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PG (29.6% ROE) versus MRK (5.1% ROE) capital efficiency.
In options market volatility and institutional positioning, PG carries 15.0% implied volatility (12th %ile, Compressed (<25th %ile)), a 0.59x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a SURGE options structure phase (0.02β · 21% Vol realized risk). By comparison, MRK carries 64.7% implied volatility (79th %ile, Elevated (60th–80th %ile)), a 0.83x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.23β · 34% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.